Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | ABCB1 | P08183 | 13/20 | 0.45 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.44 |
| ▸ | F10 | P00742 | 3/20 | 0.41 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5086331 | 0.80 | ALDH1A1 (0.63) | ALDH1A1CYP3A4MAPK1SMN1; SMN2MEN1 | |
| SCHEMBL5086354 | 0.80 | ALDH1A1 (0.63) | ALDH1A1CYP3A4MAPK1SMN1; SMN2MEN1 | |
| Catechin Pentaacetate SCHEMBL719419 | 0.76 | ALDH1A1 (1.00) | ALDH1A1CYP3A4MAPK1SMN1; SMN2MEN1 | |
| (+/-)-Pentaacetylcatechin SCHEMBL719420 | 0.76 | ALDH1A1 (1.00) | ALDH1A1CYP3A4MAPK1SMN1; SMN2MEN1 | |
| Epicatechin Pentaacetate SCHEMBL14691288 | 0.76 | ALDH1A1 (1.00) | ALDH1A1CYP3A4MAPK1SMN1; SMN2MEN1 | |
| (+/-)-Pentaacetylcatechin SCHEMBL14701425 | 0.76 | ALDH1A1 (1.00) | ALDH1A1CYP3A4MAPK1SMN1; SMN2MEN1 | |
| SCHEMBL17138200 | 0.75 | GAA (0.43) | ALDH1A1CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL5086350 | 0.73 | XDH (0.54) | ALDH1A1CYP3A4MAPK1SMN1; SMN2MEN1 | |
| SCHEMBL23496268 | 0.73 | SYNJ2 (0.50) | ALDH1A1CYP3A4MAPK1SMN1; SMN2MEN1 | |
| SCHEMBL13099988 | 0.72 | ALDH1A1 (0.53) | ALDH1A1CYP3A4MAPK1SMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | RNS CO.,LTD. (KR) | 2015-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | HRH3, CBR3, H1-0 | ALDH1A1 133/4885CYP3A4 1037/4885MAPK1 1198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.